Annual Non Current Assets
$649.00 K
+$111.00 K+20.63%
01 December 2023
Summary:
COSCIENS Biopharma annual long term assets is currently $649.00 thousand, with the most recent change of +$111.00 thousand (+20.63%) on 01 December 2023. During the last 3 years, it has fallen by -$8.63 million (-93.01%).CSCI Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$15.55 M
-$1.29 M-7.66%
01 September 2024
Summary:
COSCIENS Biopharma quarterly long term assets is currently $15.55 million, with the most recent change of -$1.29 million (-7.66%) on 01 September 2024. Over the past year, it has increased by +$3.04 million (+24.26%).CSCI Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +24.3% |
3 y3 years | -93.0% | +6.3% |
5 y5 years | -92.8% | -2.6% |
CSCI Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -99.7% | -46.8% |
COSCIENS Biopharma Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $15.55 M(-7.7%) |
June 2024 | - | $16.84 M(+29.9%) |
Mar 2024 | - | $12.96 M(+3.6%) |
Dec 2023 | $36.37 M(-34.5%) | $12.51 M(+6.7%) |
Sept 2023 | - | $11.73 M(-4.4%) |
June 2023 | - | $12.26 M(-0.6%) |
Mar 2023 | - | $12.34 M(-2.4%) |
Dec 2022 | $55.49 M(-21.6%) | $12.63 M(+0.0%) |
Sept 2022 | - | $12.63 M(-7.9%) |
June 2022 | - | $13.71 M(-5.3%) |
Mar 2022 | - | $14.48 M(-1.0%) |
Dec 2021 | $70.82 M(+156.5%) | $14.62 M(-3.6%) |
Sept 2021 | - | $15.18 M(-4.0%) |
June 2021 | - | $15.82 M(-0.5%) |
Mar 2021 | - | $15.89 M(+0.4%) |
Dec 2020 | $27.61 M(+153.1%) | $15.82 M(+7.5%) |
Sept 2020 | - | $14.72 M(+0.6%) |
June 2020 | - | $14.63 M(+1.6%) |
Mar 2020 | - | $14.40 M(-9.8%) |
Dec 2019 | $10.91 M(-32.9%) | $15.97 M(-1.5%) |
Sept 2019 | - | $16.21 M(-1.5%) |
June 2019 | - | $16.46 M(-0.3%) |
Mar 2019 | - | $16.52 M(+17.2%) |
Dec 2018 | $16.26 M(+73.3%) | $14.09 M(-6.7%) |
Sept 2018 | - | $15.10 M(+2.9%) |
June 2018 | - | $14.68 M(-0.4%) |
Mar 2018 | - | $14.73 M(-1.5%) |
Dec 2017 | $9.38 M(-58.8%) | $14.96 M(+12.3%) |
Sept 2017 | - | $13.32 M(+6.0%) |
June 2017 | - | $12.57 M(+6.9%) |
Mar 2017 | - | $11.75 M(+5.3%) |
Dec 2016 | $22.74 M(-46.4%) | $11.16 M(-1.6%) |
Sept 2016 | - | $11.34 M(+4.9%) |
June 2016 | - | $10.81 M(+7.0%) |
Mar 2016 | - | $10.10 M(+18.2%) |
Dec 2015 | $42.39 M(+17.1%) | $8.54 M(+37.2%) |
Sept 2015 | - | $6.23 M(+10.4%) |
June 2015 | - | $5.64 M(+12.9%) |
Mar 2015 | - | $5.00 M(-3.9%) |
Dec 2014 | $36.22 M(-20.7%) | $5.20 M(+10.4%) |
Sept 2014 | - | $4.71 M(+7.3%) |
June 2014 | - | $4.39 M(+46.4%) |
Mar 2014 | - | $3.00 M(+63.9%) |
Dec 2013 | $45.66 M(-14.3%) | $1.83 M(+34.5%) |
Sept 2013 | - | $1.36 M(+0.9%) |
June 2013 | - | $1.35 M(-7.1%) |
Mar 2013 | - | $1.45 M(-4.3%) |
Dec 2012 | $53.30 M(-11.4%) | $1.52 M(-34.4%) |
Sept 2012 | - | $2.31 M(+1.5%) |
June 2012 | - | $2.28 M(-2.8%) |
Mar 2012 | - | $2.34 M(+3.7%) |
Dec 2011 | $60.14 M(+36.1%) | $2.26 M(+48.3%) |
Sept 2011 | - | $1.52 M(-9.0%) |
June 2011 | - | $1.67 M(-3.4%) |
Mar 2011 | - | $1.73 M(+1.2%) |
Dec 2010 | $44.17 M | $1.71 M(+4.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $1.64 M(-1.3%) |
June 2010 | - | $1.66 M(-7.9%) |
Mar 2010 | - | $1.81 M(-1.7%) |
Dec 2009 | $49.01 M(-20.6%) | $1.84 M(-1.9%) |
Sept 2009 | - | $1.87 M(+5.2%) |
June 2009 | - | $1.78 M(+4.7%) |
Mar 2009 | - | $1.70 M(-7.1%) |
Dec 2008 | $61.72 M(+3.6%) | $1.83 M(-17.8%) |
Sept 2008 | - | $2.23 M(-5.1%) |
June 2008 | - | $2.35 M(-0.7%) |
Mar 2008 | - | $2.36 M(+1.3%) |
Dec 2007 | $59.58 M(-41.4%) | $2.33 M(+14.4%) |
Sept 2007 | - | $2.04 M(+53.6%) |
June 2007 | - | $1.33 M(+87.2%) |
Mar 2007 | - | $709.10 K(+6.2%) |
Dec 2006 | $101.72 M(-37.9%) | $667.90 K(+3.5%) |
Sept 2006 | - | $645.40 K(+14.6%) |
June 2006 | - | $563.40 K(+0.4%) |
Mar 2006 | - | $561.30 K(-4.1%) |
Dec 2005 | $163.68 M(+35.9%) | $585.20 K(+0.4%) |
Sept 2005 | - | $582.90 K(-0.6%) |
June 2005 | - | $586.60 K(-6.1%) |
Mar 2005 | - | $624.40 K(-4.3%) |
Dec 2004 | $120.41 M(+16.0%) | $652.60 K(+37.3%) |
Sept 2004 | - | $475.40 K(+75.9%) |
June 2004 | - | $270.30 K(+2.8%) |
Mar 2004 | - | $262.90 K(-1.8%) |
Dec 2003 | $103.83 M(-7.4%) | $267.70 K(+0.5%) |
Sept 2003 | - | $266.50 K(-5.6%) |
June 2003 | - | $282.40 K(+7.5%) |
Mar 2003 | - | $262.80 K(+51.3%) |
Dec 2002 | $112.07 M(+102.0%) | $173.70 K(+218.7%) |
Sept 2002 | - | $54.50 K(-10.5%) |
June 2002 | - | $60.90 K(+2.4%) |
Mar 2002 | - | $59.50 K(-6.0%) |
Dec 2001 | $55.49 M(+7.2%) | $63.30 K(+5.5%) |
Sept 2001 | - | $60.00 K(-9.9%) |
June 2001 | - | $66.60 K(-1.8%) |
Mar 2001 | - | $67.80 K(-10.4%) |
Dec 2000 | $51.79 M(+69.3%) | $75.70 K(-4.5%) |
Sept 2000 | - | $79.30 K(+17.5%) |
June 2000 | - | $67.50 K(-1.9%) |
Mar 2000 | - | $68.80 K(+9.0%) |
Dec 1999 | $30.59 M(+24.9%) | $63.10 K(-69.1%) |
Sept 1999 | - | $204.30 K(+0.4%) |
June 1999 | - | $203.50 K(+2.4%) |
Mar 1999 | - | $198.80 K(+1.9%) |
Dec 1998 | $24.50 M(-24.8%) | $195.00 K(-95.3%) |
Sept 1998 | - | $4.13 M(-52.3%) |
June 1998 | - | $8.64 M(-2.6%) |
Mar 1998 | - | $8.88 M(-0.8%) |
Dec 1997 | $32.56 M(+22.3%) | $8.94 M(-60.5%) |
Sept 1997 | - | $22.66 M(-0.4%) |
June 1997 | - | $22.74 M(-22.1%) |
Mar 1997 | - | $29.20 M |
Dec 1996 | $26.63 M | - |
FAQ
- What is COSCIENS Biopharma annual long term assets?
- What is the all time high annual non current assets for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly long term assets?
- What is the all time high quarterly non current assets for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly non current assets year-on-year change?
What is COSCIENS Biopharma annual long term assets?
The current annual non current assets of CSCI is $649.00 K
What is the all time high annual non current assets for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual long term assets is $256.11 M
What is COSCIENS Biopharma quarterly long term assets?
The current quarterly non current assets of CSCI is $15.55 M
What is the all time high quarterly non current assets for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly long term assets is $29.20 M
What is COSCIENS Biopharma quarterly non current assets year-on-year change?
Over the past year, CSCI quarterly long term assets has changed by +$3.04 M (+24.26%)